「SP全体」への1件のフィードバック

  1. The doubling in pCR rate observed with the addition of lapatinib to trastuzumab in the NeoALTTO trial did not translate into improved survival outcomes in the ALTTO trial at 4 buy priligy paypal Hi Yaninad86 and Minngirl28, I just wanted to find out how things went

コメントを残す

メールアドレスが公開されることはありません。